Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation. | Cell Death Dis | 2022 | 35013128 | PubTator, text mining | PubMed |
| METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis. | J Exp Clin Cancer Res | 2022 | 35012593 | PubTator, text mining | PubMed |
| Desmoglein-3 induces YAP phosphorylation and inactivation during collective migration of oral carcinoma cells. | Mol Oncol | 2022 | 35000271 | PubTator, text mining | PubMed |
| Skeletal muscle phenotyping of Hippo gene-mutated mice reveals that Lats1 deletion increases the percentage of type I muscle fibers. | Transgenic Res | 2022 | 34984591 | PubTator, text mining | PubMed |
| Role of hsa_circ_0066966 in proliferation and migration of hepatitis B virus-related liver cancer cells. | Exp Ther Med | 2022 | 34976133 | PubTator, text mining | PubMed |
| Decellularized extracellular matrix mediates tissue construction and regeneration. | Front Med | 2022 | 34962624 | PubTator, text mining | PubMed |
| Loss of USP28 and SPINT2 expression promotes cancer cell survival after whole genome doubling. | Cell Oncol (Dordr) | 2022 | 34962618 | PubTator, text mining | PubMed |
| Long non-coding RNA FAM66C regulates glioma growth via the miRNA/LATS1 signaling pathway. | Biol Chem | 2022 | 34954927 | PubTator, text mining | PubMed |
| Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome. | Mod Pathol | 2022 | 34949764 | PubTator, text mining | PubMed |
| Circulating miRNA expression over the course of colorectal cancer treatment. | Oncol Lett | 2022 | 34868358 | PubTator, text mining | PubMed |
| Licochalcone A inhibits cell growth through the downregulation of the Hippo pathway via PES1 in cholangiocarcinoma cells. | Environ Toxicol | 2022 | 34845814 | PubTator, text mining | PubMed |
| Electrochemically derived nanographene oxide activates endothelial tip cells and promotes angiogenesis by binding endogenous lysophosphatidic acid. | Bioact Mater | 2022 | 34820558 | PubTator, text mining | PubMed |
| Hierarchy of TGFβ/SMAD, Hippo/YAP/TAZ, and Wnt/β-catenin signaling in melanoma phenotype switching. | Life Sci Alliance | 2022 | 34819356 | PubTator, text mining | PubMed |
| Inhibitors of the Hippo Pathway Kinases STK3/MST2 and STK4/MST1 Have Utility for the Treatment of Acute Myeloid Leukemia. | J Med Chem | 2022 | 34807584 | PubTator, text mining | PubMed |
| An emergent Wnt5a/YAP/TAZ regulatory circuit and its possible role in cancer. | Semin Cell Dev Biol | 2022 | 34764023 | PubTator, text mining | PubMed |
| Loss of SPTBN1 Suppresses Autophagy Via SETD7-mediated YAP Methylation in Hepatocellular Carcinoma Initiation and Development. | Cell Mol Gastroenterol Hepatol | 2022 | 34737104 | PubTator, text mining | PubMed |
| Molecular characterization of pleomorphic mesothelioma: a multi-institutional study. | Mod Pathol | 2022 | 34531524 | PubTator, text mining | PubMed |
| Targeting the Hippo pathway in heart repair. | Cardiovasc Res | 2022 | 34528077 | PubTator, text mining | PubMed |
| Paris saponin VII, a Hippo pathway activator, induces autophagy and exhibits therapeutic potential against human breast cancer cells. | Acta Pharmacol Sin | 2022 | 34522004 | PubTator, text mining | PubMed |
| Signet ring cell cancer of stomach and gastro-esophageal junction: molecular alterations, stage-stratified treatment approaches, and future challenges. | Langenbecks Arch Surg | 2022 | 34505199 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=48